The invention relates to the use of 4, 6-di(3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecan-1-yl)-2-methyl-5-nitropyrimidine tetrachloride dihydrochloride hexahydrate exhibiting activity against herpes virus, for the prevention and treatment of herpetic infections in humans and animals by topical administration.
该发明涉及使用对单核病毒具有活性的4,6-二(3,12-二氮杂-6,9-二氮杂二螺[5.2.5.2]
十六烷基)-2-甲基-5-
硝基嘧啶四
氯化物二盐酸盐六
水合物,通过局部给药预防和治疗人类和动物的单纯疱疹感染。